Tickwind
TodayOpportunitiesMarketsHotNewsAI Chat
What's new
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/Compare

ISRG vs MDT

ISRG and MDT side by side — valuation & fundamentals (public data).

Key statistics

ISRG vs MDT key statistics
MetricISRGIntuitive Surgical, Inc.MDTMedtronic plc
Market cap$133.84B$111.57B
P/E (TTM)43.423.4
P/B7.372.26
P/S13.3x3.1x
Dividend yield—3.26%
Revenue$11.03B(TTM)$36.36B(TTM)
Revenue growth (YoY)20.5%8.4%
Net income$3.14B(TTM)$4.80B(TTM)
Earnings growth (YoY)23.0%3.0%
EPS, diluted$8.72(TTM)$3.73(TTM)
EBIT margin29.3%17.8%
ROE15.7%9.7%
ROIC—7.1%
Piotroski F—8/9
1y total return-19.2%-1.4%

Figures from SEC filings · for reference only · not investment advice

Growth of $10,000: ISRG vs MDT

$10.0K$54.5K$14.4K2016-04-062026-08-07
MetricISRGMDT
End value$54.5K$14.4K
Total return+444.5%+44.3%
CAGR+17.8%+3.6%
Volatility32.6%23.2%
Sharpe0.550.10
Sortino0.790.14
Max drawdown-49.9%-45.3%

Based on 2600 common trading days, 2016-04-06 → 2026-08-07 · risk-free 3.87% (current short-Treasury, held constant)

A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.

Related comparisons

ISRG vs SYKBSX vs ISRGMDT vs SYKBSX vs MDTABT vs MDTAAPL vs MSFT

Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)